Patients In Genome-Editing Trial Show Early Signs Of Improvement.

STAT Plus (9/5, Feuerstein, Subscription Publication) reports that two patients who have been “injected with a groundbreaking genome-editing fix” are “showing early signs of improvement” from a rare, inherited disease called MPS II or Hunter syndrome. Th...